{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:02:32Z","timestamp":1790928152141,"version":"4.1.0"},"reference-count":45,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation Coeur Recherche"},{"name":"Federation Francaise de Cardiologie"},{"DOI":"10.13039\/501100020407","name":"ERA-CVD","doi-asserted-by":"crossref","award":["JTC 2019"],"award-info":[{"award-number":["JTC 2019"]}],"id":[{"id":"10.13039\/501100020407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Clonal hematopoiesis of indeterminate potential (CHIP) was initially linked to a twofold increase in atherothrombotic events. However, recent investigations have revealed a more nuanced picture, suggesting that CHIP may confer only a modest rise in myocardial infarction (MI) risk. This observed lower risk might be influenced by yet unidentified factors that modulate the pathological effects of CHIP. Mosaic loss of the Y chromosome (mLOY), a common marker of clonal hematopoiesis in men, has emerged as a potential candidate for modulating cardiovascular risk associated with CHIP. In this study, we aimed to ascertain the risk linked to each somatic mutation or mLOY and explore whether mLOY could exert an influence on the cardiovascular risk associated with CHIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted an examination for the presence of CHIP and mLOY using targeted high-throughput sequencing and digital PCR in a cohort of 446 individuals. Among them, 149 patients from the CHAth study had experienced a first MI at the time of inclusion (MI(+) subjects), while 297 individuals from the Three-City cohort had no history of cardiovascular events (CVE) at the time of inclusion (MI(-) subjects). All subjects underwent thorough cardiovascular phenotyping, including a direct assessment of atherosclerotic burden. Our investigation aimed to determine whether mLOY could modulate inflammation, atherosclerosis burden, and atherothrombotic risk associated with CHIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CHIP and mLOY were detected with a substantial prevalence (45.1% and 37.7%, respectively), and their occurrence was similar between MI(+) and MI(-) subjects. Notably, nearly 40% of CHIP(+) male subjects also exhibited mLOY. Interestingly, neither CHIP nor mLOY independently resulted in significant increases in plasma hs-CRP levels, atherosclerotic burden, or MI incidence. Moreover, mLOY did not amplify or diminish inflammation, atherosclerosis, or MI incidence among CHIP(+) male subjects. Conversely, in MI(-) male subjects, CHIP heightened the risk of MI over a 5 y period, particularly in those lacking mLOY.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study highlights the high prevalence of CHIP and mLOY in elderly individuals. Importantly, our results demonstrate that neither CHIP nor mLOY in isolation substantially contributes to inflammation, atherosclerosis, or MI incidence. Furthermore, we find that mLOY does not exert a significant influence on the modulation of inflammation, atherosclerosis burden, or atherothrombotic risk associated with CHIP. However, CHIP may accelerate the occurrence of MI, especially when unaccompanied by mLOY. These findings underscore the complexity of the interplay between CHIP, mLOY, and cardiovascular risk, suggesting that large-scale studies with thousands more patients may be necessary to elucidate subtle correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>This study was supported by the Fondation C\u0153ur &amp; Recherche (the Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie), the F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie, ERA-CVD (\u00ab CHEMICAL \u00bb consortium, JTC 2019) and the Fondation Universit\u00e9 de Bordeaux. The laboratory of Hematology of the University Hospital of Bordeaux benefitted of a convention with the Nouvelle Aquitaine Region (2018-1R30113-8473520) for the acquisition of the Nextseq 550Dx sequencer used in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs6\">\n                    <jats:title>Clinical trial number:<\/jats:title>\n                    <jats:p>\n                      <jats:related-object document-id=\"NCT04581057\" document-id-type=\"clinical-trial-number\" id=\"RO1\" source-id=\"ClinicalTrials.gov\" source-id-type=\"registry-name\" source-type=\"clinical-trials-registry\" xlink:href=\"https:\/\/clinicaltrials.gov\/show\/NCT04581057\">NCT04581057<\/jats:related-object>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.96150","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:26:20Z","timestamp":1714652780000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.96150","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies"],"prefix":"10.7554","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct04581057","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sami","family":"Fawaz","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Service des Maladies Coronaires et Vasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Severine","family":"Marti","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Laboratoire d'hematologie","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Melody","family":"Dufossee","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0463z7496","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, INSERM, Biologie des maladies cardiovasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Yann","family":"Pucheu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Service des Maladies Coronaires et Vasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Astrid","family":"Gaufroy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Service des Maladies Coronaires et Vasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Jean","family":"Broitman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Service des Maladies Coronaires et Vasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Audrey","family":"Bidet","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Laboratoire d'hematologie","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Aicha","family":"Soumare","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, Bordeaux Population Health Research Center, INSERM","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-9825","authenticated-orcid":true,"given":"Ga\u00eblle","family":"Munsch","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, Bordeaux Population Health Research Center, INSERM","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-2984","authenticated-orcid":true,"given":"Christophe","family":"Tzourio","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, Bordeaux Population Health Research Center, INSERM","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Stephanie","family":"Debette","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, Bordeaux Population Health Research Center, INSERM","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-7800","authenticated-orcid":true,"given":"David-Alexandre","family":"Tr\u00e9gou\u00ebt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057qpr032","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, Bordeaux Population Health Research Center, INSERM","place":["Bordeaux, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Chloe","family":"James","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Laboratoire d'hematologie","place":["Pessac, France"]},{"id":[{"id":"https:\/\/ror.org\/0463z7496","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, INSERM, Biologie des maladies cardiovasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-8800","authenticated-orcid":true,"given":"Olivier","family":"Mansier","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Laboratoire d'hematologie","place":["Pessac, France"]},{"id":[{"id":"https:\/\/ror.org\/0463z7496","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, INSERM, Biologie des maladies cardiovasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Thierry","family":"Couffinhal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hq89f96","id-type":"ROR","asserted-by":"publisher"}],"name":"CHU de Bordeaux, Service des Maladies Coronaires et Vasculaires","place":["Pessac, France"]},{"id":[{"id":"https:\/\/ror.org\/0463z7496","id-type":"ROR","asserted-by":"publisher"}],"name":"Univ. Bordeaux, INSERM, Biologie des maladies cardiovasculaires","place":["Pessac, France"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000072920","type":"journal-article","article-title":"Vascular factors and risk of dementia: Design of the three-city study and baseline characteristics of the study population","volume":"22","author":"3C Study Group","year":"2003","journal-title":"Neuroepidemiology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.120.317104","type":"journal-article","article-title":"Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure","volume":"128","author":"Abplanalp","year":"2021","journal-title":"Circulation Research"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","type":"journal-article","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1182\/blood.2022017661","type":"journal-article","article-title":"Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke","volume":"141","author":"Arends","year":"2023","journal-title":"Blood"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","type":"journal-article","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1012848","type":"journal-article","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","type":"journal-article","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jacc.2022.08.740","type":"journal-article","article-title":"Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction","volume":"80","author":"B\u00f6hme","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1182\/bloodadvances.2019000770","type":"journal-article","article-title":"High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential","volume":"4","author":"Busque","year":"2020","journal-title":"Blood Advances"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","type":"journal-article","article-title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","volume":"3","author":"Cook","year":"2019","journal-title":"Blood Advances"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1093\/rheumatology\/keac108","type":"journal-article","article-title":"Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)","volume":"61","author":"David","year":"2022","journal-title":"Rheumatology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.2966","type":"journal-article","article-title":"Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer","volume":"46","author":"Forsberg","year":"2014","journal-title":"Nature Genetics"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","type":"journal-article","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","type":"journal-article","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1182\/bloodadvances.2020001582","type":"journal-article","article-title":"High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers","volume":"4","author":"Guermouche","year":"2020","journal-title":"Blood Advances"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004415","type":"journal-article","article-title":"Invasive assessment of coronary artery disease in clonal hematopoiesis of indeterminate potential","volume":"17","author":"Heimlich","year":"2024","journal-title":"Circulation. Genomic and Precision Medicine"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","type":"journal-article","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","type":"journal-article","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","type":"journal-article","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nature Genetics"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","type":"journal-article","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","type":"journal-article","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/2047487311434107","type":"journal-article","article-title":"Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome","volume":"20","author":"Lafitte","year":"2013","journal-title":"European Journal of Preventive Cardiology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","type":"journal-article","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"The Journal of Molecular Diagnostics"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41375-021-01456-2","type":"journal-article","article-title":"Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?","volume":"36","author":"Ljungstr\u00f6m","year":"2022","journal-title":"Leukemia"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30759-1","type":"journal-article","article-title":"Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank","volume":"8","author":"Loftfield","year":"2018","journal-title":"Scientific Reports"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/bloodadvances.2020003444","type":"journal-article","article-title":"Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study","volume":"5","author":"Luque Paz","year":"2021","journal-title":"Blood Advances"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","type":"journal-article","article-title":"Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"41","author":"Mas-Peiro","year":"2020","journal-title":"European Heart Journal"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/eurheartj\/ehad093","type":"journal-article","article-title":"Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement","volume":"44","author":"Mas-Peiro","year":"2023","journal-title":"European Heart Journal"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/STROKEAHA.122.041416","type":"journal-article","article-title":"Prevalence and therapeutic implications of clonal hematopoiesis of indeterminate potential in young patients with stroke","volume":"54","author":"Mayerhofer","year":"2023","journal-title":"Stroke"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","type":"journal-article","article-title":"Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction","volume":"77","author":"Pascual-Figal","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","type":"journal-article","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"European Heart Journal"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41591-021-01411-9","type":"journal-article","article-title":"Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis","volume":"27","author":"Saiki","year":"2021","journal-title":"Nature Medicine"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.abn3100","type":"journal-article","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","type":"journal-article","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","type":"journal-article","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","type":"journal-article","article-title":"Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u226580 years","volume":"5","author":"van Zeventer","year":"2021","journal-title":"Blood Advances"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1161\/CIRCULATIONAHA.122.062126","type":"journal-article","article-title":"Interleukin-6 receptor polymorphism attenuates clonal hematopoiesis-mediated coronary artery disease risk among 451 180 individuals in the UK Biobank","volume":"147","author":"Vlasschaert","year":"2023","journal-title":"Circulation"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood.2022018825","type":"journal-article","article-title":"A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets","volume":"141","author":"Vlasschaert","year":"2023","journal-title":"Blood"},{"key":"bib39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103964","type":"journal-article","article-title":"Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction","volume":"78","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ng.3821","type":"journal-article","article-title":"Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility","volume":"49","author":"Wright","year":"2017","journal-title":"Nature Genetics"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","type":"journal-article","article-title":"TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease","volume":"2","author":"Zekavat","year":"2023","journal-title":"Nature Cardiovascular Research"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamacardio.2023.5095","type":"journal-article","article-title":"Somatic and germline variants and coronary heart disease in a chinese population","volume":"9","author":"Zhao","year":"2024","journal-title":"JAMA Cardiology"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ng.3545","type":"journal-article","article-title":"Mosaic loss of chromosome Y is associated with common variation near TCL1A","volume":"48","author":"Zhou","year":"2016","journal-title":"Nature Genetics"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","type":"journal-article","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"dataset2","type":"dataset","article-title":"Frequency of clonal haematopoiesis in patients with a first cardiovascular event after 75 years of age: Consequences on inflammation","volume-title":"European Variation Archive","author":"Couffinhal","year":"2024","unstructured":"Couffinhal T, Mansier O. 2024. Frequency of clonal haematopoiesis in patients with a first cardiovascular event after 75 years of age: Consequences on inflammation. European Variation Archive. https:\/\/www.ebi.ac.uk\/eva\/?eva-study=PRJEB82347. PRJEB82347."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/96150\/elife-96150-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/96150\/elife-96150-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/96150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:02:49Z","timestamp":1787565769000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/96150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":45,"alternative-id":["10.7554\/eLife.96150"],"URL":"https:\/\/doi.org\/10.7554\/elife.96150","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.15.24301313","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2024.01.15.24301313","asserted-by":"object"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.96150.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.96150.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.96150.2","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"PRJEB82347","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP96150"}}